GleamWall
中文EN

ADGM Adagio Medical Holdings, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 2006986 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY—
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE9.6%
ROA2.7%
ROIC (approx.)-89.9%
Asset turnover0.00x

Leverage & solvency

Liabilities / assets38.5%
Debt / equity0.11x
Current ratio0.90x
Interest coverage-5.77x

Cash quality & payout

Operating cash flow / net income-22.06x
Accruals ratio61.7%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q3*2024-09-30
Income statement
Revenue$0$0$0$0$0$0$0—
Cost of revenue———$58,000$31,000$342,000$253,000—
Gross profit———-$58,000-$31,000-$342,000-$253,000—
R&D expense$1.80M$2.45M$2.74M$2.23M$2.77M$1.97M$3.66M—
SG&A expense$2.57M$2.48M$2.46M$1.68M$2.92M$2.40M$3.48M—
Operating income-$4.37M-$4.93M-$5.20M-$3.97M-$5.72M-$4.72M-$7.40M—
Interest expense$843,000$805,000$778,000$775,000$749,000$720,000$662,000—
Net income$17.84M-$6.72M-$7.00M-$3.31M-$10.12M-$3.95M-$7.71M-$8.23M
EBITDA-$4.17M-$4.73M-$4.99M-$3.73M-$5.52M-$4.52M-$7.13M—
EPS (basic)2.40-0.30-0.31—-19.73-0.26-0.50-8.34
EPS (diluted)-5.13-0.30-0.31—-19.73-0.35-0.51—
Weighted avg. shares (diluted)833,25422.21M22.21M—512,71815.38M15.38M—
Balance sheet
Cash & equivalents$3.10M$7.74M$12.91M$17.11M$4.67M$8.20M$12.96M$28.26M
Receivables——————$1,000$90,000
Inventory$2.72M$1.99M$1.60M$1.67M$1.55M$1.84M$2.31M$4.14M
Current assets$6.91M$10.69M$15.86M$20.08M$8.14M$12.23M$17.37M$35.03M
PP&E, net$939,000$1.13M$1.32M$1.53M$1.70M$1.88M$2.09M$1.57M
Goodwill$13.97M$13.97M$13.97M$13.97M$13.97M$13.97M$13.97M$44.29M
Intangibles$6.97M$6.97M$6.97M$6.97M$6.97M$6.97M$6.97M$26.06M
Total assets$29.86M$33.88M$39.31M$43.25M$31.55M$35.88M$41.34M$107.20M
Current liabilities$7.72M$7.56M$8.57M$8.23M$9.70M$4.88M$6.01M$7.92M
Long-term debt$2.01M$24.84M$22.87M$21.04M$21.19M$16.95M$17.65M$13.75M
Total debt$2.01M$24.84M$22.87M$21.04M$21.19M$16.95M$17.65M$13.75M
Total liabilities$11.50M$34.30M$33.58M$30.85M$32.86M$27.21M$28.94M$30.64M
Shareholders' equity$18.36M-$415,000$5.72M$12.40M-$1.31M$8.67M$12.40M$76.56M
Net debt-$1.08M$17.10M$9.96M$3.94M$16.52M$8.74M$4.69M-$14.51M
Shares outstanding889,64422.21M22.21M740,34815.38M15.38M15.38M14.54M
Cash flow statement
Operating cash flow-$4.61M-$5.26M-$4.13M-$4.14M-$3.01M-$4.66M-$7.21M—
Capital expenditure$4,000$6,000$2,000-$491,000$520,000$10,000$335,000—
Free cash flow-$4.61M-$5.27M-$4.13M-$3.65M-$3.53M-$4.67M-$7.55M—
Investing cash flow-$4,000-$6,000-$2,000$491,000-$520,000-$10,000-$335,000—
Depreciation & amortization$200,000$200,000$210,000$237,000$200,000$200,000$271,000—
Stock-based compensation$218,000$479,000$389,000$890,000$137,000$234,000$218,000—

Free plan shows the latest 8 periods; Pro shows all 12 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.